CTOIJ HomeEditorial February 18, 2026
Rare Aggressive B-Cell Lymphomas: Challenge for a Pathologist, Challenge for a Clinician 1. Plasmablastic lymphoma
Nahla A. M. Hamed*
Cancer therapy & Oncology International Journal is dedicated to publish the contributions on all aspects of experimental and clinical cancer research. CTOIJ is a multidisciplinary, open access, peer reviewed journal accepts Research, Review Articles, Short Communications, Mini- Review, Case Reports, Opinions, Letter to Editors etc., Authors are requested to submit complete unpublished and original works, including but not limited to the following fields: cancer biology, cancer science and therapeutics, cancer nanotechnology, cancer detection and prevention, radiology, radiation oncology, radiation therapy, medical and clinical oncology. CTOIJ providing a platform for researchers, scholars, clinicians and academicians to collaborate and share knowledge.
Nahla A. M. Hamed*
K Ramalingam*, Babu K and S Paulraj
Ahmadu Ibrahim*
Ferrat Dincoglan*, Murat Beyzadeoglu, Selcuk Demiral and Omer Sager
Nahla A. M. Hamed*
Mustafa Akin*
Mustafa Akin*
Ahmadu Ibrahim*, Dalhatu Muhammad, Sani Bello, Baba Jacob Buba, Umaru Musa and Kadala Yakubu Mbaya
Open Access by Juniper Publishers is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at www.juniperpublishers.com. 
| Above IE 7.0 version | Privacy Policy
